Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells
about
Conjoint propagation and differentiation of human embryonic stem cells to cardiomyocytes in a defined microcarrier spinner cultureHeart regenerationDifferentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overviewGrowth of engineered human myocardium with mechanical loading and vascular cocultureHuman Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease ModelingReprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand?Programming and reprogramming a human heart cellMechanical Stress Promotes Maturation of Human Myocardium From Pluripotent Stem Cell-Derived Progenitors.Inhibition of β-catenin signaling respecifies anterior-like endothelium into beating human cardiomyocytes.A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variabilityClinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine.Strategies and Challenges to Myocardial Replacement TherapySignaling Pathways and Gene Regulatory Networks in Cardiomyocyte DifferentiationActivin-A and Bmp4 levels modulate cell type specification during CHIR-induced cardiomyogenesisInsulin inhibits cardiac mesoderm, not mesendoderm, formation during cardiac differentiation of human pluripotent stem cells and modulation of canonical Wnt signaling can rescue this inhibitionWnt/β-catenin signaling directs the regional expansion of first and second heart field-derived ventricular cardiomyocytes.The molecular aspects of chordoma.Embryonic origins of human vascular smooth muscle cells: implications for in vitro modeling and clinical applicationRegenerative chemical biology: current challenges and future potentialEvidence that gene activation and silencing during stem cell differentiation requires a transcriptionally paused intermediate stateFolate protection from congenital heart defects linked with canonical Wnt signaling and epigenetics.Chemically defined generation of human cardiomyocytesProduction of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming.A blueprint for engineering cell fate: current technologies to reprogram cell identity.The complex SNP and CNV genetic architecture of the increased risk of congenital heart defects in Down syndrome.DMH1, a novel BMP small molecule inhibitor, increases cardiomyocyte progenitors and promotes cardiac differentiation in mouse embryonic stem cells.Peptidomimetic small-molecule compounds promoting cardiogenesis of stem cells.The long-term differentiation of embryonic stem cells into cardiomyocytes: an indirect co-culture model.A potential relationship among beta-defensins haplotype, SOX7 duplication and cardiac defects.SHOX2 overexpression favors differentiation of embryonic stem cells into cardiac pacemaker cells, improving biological pacing ability.Inhibition of adipocytogenesis by canonical WNT signaling in human mesenchymal stem cellsAn optimized and simplified system of mouse embryonic stem cell cardiac differentiation for the assessment of differentiation modifiers.Differentiation of human pluripotent stem cells into nephron progenitor cells in a serum and feeder free system.Reprogramming for cardiac regeneration.Canonical WNT signaling enhances stem cell expression in the developing heart without a corresponding inhibition of cardiogenic differentiationThe current status of iPS cells in cardiac research and their potential for tissue engineering and regenerative medicine.Statistically based splicing detection reveals neural enrichment and tissue-specific induction of circular RNA during human fetal developmentRobust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling.Recent Progress on Chemical Biology of Pluripotent Stem Cell Self-renewal, Reprogramming and CardiomyogenesisHuman pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair.
P2860
Q21999310-3ED73FD8-637D-4088-ACA5-530F4C323ADBQ24562846-6404CE1F-FEE5-4E19-AB93-662588346C52Q24618089-6C7F3559-A12C-4B9E-9668-256E1FC28429Q24630666-E27478B8-ABB3-4624-895C-6518BEB4DA52Q26750618-8EF22D94-5733-4C4F-98FC-B36F6FA4CCA2Q26800082-198A2E43-3012-40AC-A0F4-216051BEB79BQ26823933-B2F99BFD-D970-42C7-A549-277BF23748A5Q27329454-BE40028B-12C9-446C-95C2-C11B8461F170Q27345392-12B54DF1-4D45-4F2F-850A-8D2DD2BAA147Q27349038-5E0E67E7-0668-4850-9939-2C1F0DB703C3Q27693850-0BDB15A9-3F04-44BF-B3E9-0F2EE903D823Q28068007-F0B64DC5-1D65-427D-A2D0-86135CD67533Q28087290-FAD407B0-725A-435C-BA3C-34613CF647B6Q28543620-101E46F0-A9C4-41B0-97D6-48368CD3682FQ30536707-758128C5-6E09-4A24-822C-756D5D3705ADQ30547782-6371CEA3-518B-4E68-95DC-4E2B99726A2DQ33275745-47AD1885-F27F-4A13-9BC8-909C86AFA2CCQ33651561-319F1A23-1E7A-4DC8-82D4-EFFDF5CDE34FQ33880045-B5E3C978-8A04-4FB8-8168-E337F950BC07Q34008734-F71F0A81-78CA-4FCA-B255-EE1590167409Q34138225-E3532DCA-1C8D-426D-AC7E-90081B3B9B1BQ34216549-714A866B-55C7-40CC-8006-6A8C8F908446Q34245487-01DA0303-456A-4A1B-B58A-594D8ED463B6Q34320191-F85AD380-221C-4963-BA8C-9896C11301B4Q34352054-20651745-FF33-4311-91F2-5238FE2CDBE3Q34358717-90729906-87F6-49C6-9148-97595E366678Q34501443-1C5012C0-B0B5-46D5-A196-F4562CC5E7C8Q34576247-89333120-7EC0-4A6F-94CC-2A20A80C1180Q34979568-27CBD486-0FB2-478F-B7C8-1FC0BB91386AQ34980766-9038E441-EE16-428E-8D60-47090FDC9C19Q35090349-CF779DBC-83A8-4661-9053-0FEDE9FE0518Q35131230-474DF64F-FDC2-4CAD-958E-00318E78BB9FQ35146986-DF03FA39-86CC-4CF1-A8CE-9D5DDF7B5731Q35156623-44F461A9-0605-4890-9104-A57233EE5508Q35459487-F772745B-A593-4DF0-9145-3AC2E71C64A4Q35765543-6967DC20-B32F-4386-9B3D-A9BBD7200F3BQ35863369-CE7757DD-6D98-4D54-98B6-6D451D7D7581Q36079527-AFB3DED4-076E-43E6-9D5D-C741F4DB3C44Q36083407-AF7E59BA-CAAE-4B80-BBE8-5EC6B889A35CQ36279078-25D79A90-6ECF-4D22-A990-A4BF6E57B87E
P2860
Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Endogenous Wnt/beta-catenin si ...... in human embryonic stem cells
@ast
Endogenous Wnt/beta-catenin si ...... in human embryonic stem cells
@en
Endogenous Wnt/beta-catenin si ...... in human embryonic stem cells
@en-gb
Endogenous Wnt/beta-catenin si ...... in human embryonic stem cells
@nl
type
label
Endogenous Wnt/beta-catenin si ...... in human embryonic stem cells
@ast
Endogenous Wnt/beta-catenin si ...... in human embryonic stem cells
@en
Endogenous Wnt/beta-catenin si ...... in human embryonic stem cells
@en-gb
Endogenous Wnt/beta-catenin si ...... in human embryonic stem cells
@nl
prefLabel
Endogenous Wnt/beta-catenin si ...... in human embryonic stem cells
@ast
Endogenous Wnt/beta-catenin si ...... in human embryonic stem cells
@en
Endogenous Wnt/beta-catenin si ...... in human embryonic stem cells
@en-gb
Endogenous Wnt/beta-catenin si ...... in human embryonic stem cells
@nl
P2093
P2860
P921
P3181
P1433
P1476
Endogenous Wnt/beta-catenin si ...... in human embryonic stem cells
@en
P2093
Charles E Murry
Hans Reinecke
Olga K Afanasiev
Sharon L Paige
Tomoaki Osugi
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0011134
P407
P577
2010-01-01T00:00:00Z